The incretin glucagon-like peptide-1 (GLP-1), released from the gut during food intake, amplifies glucose-stimulated insulin release by binding to and activating its cognate G protein-coupled receptor (GPCR), the GLP-1 receptor (GLP-1R), triggering cAMP generation and downstream Protein Kinase A (PKA) and Exchange Protein Activated by cyclic AMP 2 (Epac2) signalling 4 , a process that has been exploited to develop pharmacological GLP-1R agonists (GLP-1RAs) as T2D therapies
Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: A systematic review and network meta-analysis
Watch out for these warning signs: No in-person medical supervision Pressure to buy expensive supplements No clear treatment plan Missing patient reviews Sketchy pricing that seems too good to be true No follow-up care Refusing to answer questions about their medical staff Pro tip: The best clinics will always check your BMI and medical history before starting treatment
Get the Answers Here
Always consult with a qualified healthcare provider before making changes to your diet or health regimen.
Metabolic effects of repeated weight and regain in adolescent wrestlers